Candida infection study: resistance and biofilm
Part of Infections clinical trials.
This study looks at Candida infections that are hard to treat, especially when the body's defenses are weak or after medical procedures. It aims to understand why some Candida become resistant to antifungal medicines and form protective layers called biofilms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a serious infection that is not responding to usual antibiotics.
- Your immune system is weakened, either overall or in the area of the infection.
- You have had trauma or a medical procedure that might have introduced the infection.
- Tests for bacteria were negative, suggesting the infection may be fungal.
- You have not taken antifungal medicine in the last 3 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients in the intensive care unit who have a new infection with Candida (a type of fungus) despite taking strong antibiotics. It aims to better understand and diagnose these serious infections.
This study looks at how well antifungal medicines work against different fungi and how fungi become resistant. By joining, you may help doctors understand your infection and improve future treatments.
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
This study looks at immune system differences that can make some people get unusual or frequent fungal (fungus) infections. It may help researchers better understand these conditions, and you may be asked to store blood for future research.
This study is a hospital registry that collects health and test information about people with confirmed invasive Candida (a fungal infection). It may help doctors understand who gets these infections and how they spread, which can improve future diagnosis and care.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
Hear when a new Candida Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.